Manufacturer of Controlled Substances Registration: Cambridge Isotope Lab, 2237-2238 [2016-00782]

Download as PDF mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 10 / Friday, January 15, 2016 / Notices business days thereafter, or by February 29, 2016. DATES: Effective date: January 8, 2016. FOR FURTHER INFORMATION CONTACT: Michael Szustakowski (202–205–3169), Office of Investigations, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436. Hearing-impaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its internet server (https:// www.usitc.gov). The public record for these investigations may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. SUPPLEMENTARY INFORMATION: Background. These investigations are being instituted, pursuant to sections 703(a) and 733(a) of the Tariff Act of 1930 (19 U.S.C. 1671b(a) and 1673b(a)), in response to petitions filed on January 8, 2016, by Titan Tire Corporation of Des Moines, Iowa and the United Steel, Paper and Forestry, Rubber, Manufacturing, Energy, Allied Industrial and Service Workers International Union, AFL–CIO, CLC of Pittsburgh, Pennsylvania. For further information concerning the conduct of these investigations and rules of general application, consult the Commission’s Rules of Practice and Procedure, part 201, subparts A and B (19 CFR part 201), and part 207, subparts A and B (19 CFR part 207). Participation in the investigation and public service list. Persons (other than petitioners) wishing to participate in the investigations as parties must file an entry of appearance with the Secretary to the Commission, as provided in sections 201.11 and 207.10 of the Commission’s rules, not later than seven days after publication of this notice in the Federal Register. Industrial users and (if the merchandise under investigation is sold at the retail level) representative consumer organizations have the right to appear as parties in Commission antidumping duty and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to these investigations upon the expiration of the period for filing entries of appearance. Limited disclosure of business proprietary information (BPI) under an administrative protective order (APO) VerDate Sep<11>2014 20:01 Jan 14, 2016 Jkt 238001 and BPI service list. Pursuant to section 207.7(a) of the Commission’s rules, the Secretary will make BPI gathered in these investigations available to authorized applicants representing interested parties (as defined in 19 U.S.C. 1677(9)) who are parties to the investigations under the APO issued in the investigations, provided that the application is made not later than seven days after the publication of this notice in the Federal Register. A separate service list will be maintained by the Secretary for those parties authorized to receive BPI under the APO. Conference. The Commission’s Director of Investigations has scheduled a conference in connection with these investigations for 9:30 a.m. on Friday, January 29, 2016, at the U.S. International Trade Commission Building, 500 E Street SW., Washington, DC. Requests to appear at the conference should be emailed to William.bishop@usitc.gov and Sharon.bellamy@usitc.gov (do not file on EDIS) on or before January 27, 2016. Parties in support of the imposition of countervailing and antidumping duties in these investigations and parties in opposition to the imposition of such duties will each be collectively allocated one hour within which to make an oral presentation at the conference. A nonparty who has testimony that may aid the Commission’s deliberations may request permission to present a short statement at the conference. Written submissions. As provided in sections 201.8 and 207.15 of the Commission’s rules, any person may submit to the Commission on or before February 3, 2016, a written brief containing information and arguments pertinent to the subject matter of the investigations. Parties may file written testimony in connection with their presentation at the conference. If briefs or written testimony contain BPI, they must conform with the requirements of sections 201.6, 207.3, and 207.7 of the Commission’s rules. Please consult the Commission’s rules, as amended, 76 FR 61937 (Oct. 6, 2011) and the Commission’s Handbook on Filing Procedures, 76 FR 62092 (Oct. 6, 2011), available on the Commission’s Web site at https://edis.usitc.gov. In accordance with sections 201.16(c) and 207.3 of the rules, each document filed by a party to the investigations must be served on all other parties to the investigations (as identified by either the public or BPI service list), and a certificate of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service. PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 2237 Authority: These investigations are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.12 of the Commission’s rules. By order of the Commission. Issued: January 11, 2016. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2016–00618 Filed 1–14–16; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [USITC SE–16–001] Government in the Sunshine Act Meeting Notice United States International Trade Commission. TIME AND DATE: January 20, 2016 at 11:00 a.m. PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agendas for future meetings: None. 2. Minutes. 3. Ratification List. 4. Vote in Inv. No. 731–TA–125 (Fourth Review) (Potassium Permanganate from China). The Commission is currently scheduled to complete and file its determination and views of the Commission on January 29, 2016. 5. Outstanding action jackets: None. In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. AGENCY HOLDING THE MEETING: By order of the Commission. Issued: January 11, 2016. William R. Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2016–00831 Filed 1–13–16; 4:15 pm] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: Cambridge Isotope Lab ACTION: Notice of registration. Cambridge Isotope Lab applied to be registered as a SUMMARY: E:\FR\FM\15JAN1.SGM 15JAN1 2238 Federal Register / Vol. 81, No. 10 / Friday, January 15, 2016 / Notices manufacturer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Cambridge Isotope Lab registration as a manufacturer of this controlled substance. SUPPLEMENTARY INFORMATION: By notice dated October 2, 2015, and published in the Federal Register on October 13, 2015, 80 FR 61470, Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810 applied to be registered as a manufacturer of a certain basic class of controlled substance. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambridge Isotope Lab to manufacture the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of morphine (9300), a basic class of controlled substance listed in schedule II. The company plans to utilize small quantities of the listed controlled substance in the preparation of analytical standards. Dated: January 11, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–00782 Filed 1–14–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE mstockstill on DSK4VPTVN1PROD with NOTICES Notice of Filing of Proposed Stipulation and Settlement Agreement Under the Resource Conservation and Recovery Act On January 12, 2016, a proposed Stipulation and Settlement Agreement establishing an Environmental Response Trust for the Gulfport, Mississippi Facility (‘‘Gulfport Settlement Agreement’’) was filed with the United States Bankruptcy Court for the District of Delaware in the bankruptcy proceeding entitled In re Reichhold Holdings US, Inc., No. 14–12237–MFW (Bankr. D. Del.). VerDate Sep<11>2014 20:01 Jan 14, 2016 Jkt 238001 Under the proposed Gulfport Settlement Agreement, an Environmental Response Trust will be created to take title to certain property owned by Reichhold Inc., located in Gulfport, Mississippi. The Environmental Response Trust will perform certain environmental actions with respect to the property. The Environmental Response Trust will receive the proceeds of a letter of credit in the approximate amount of $3.5 million and $750,000 provided by the Debtor. The Gulfport Settlement Agreement includes covenants not to sue under the Resource Conservation and Recovery Act (‘‘RCRA’’), 42 U.S.C. 6901 et seq. The publication of this notice opens a period for public comment on the Gulfport Settlement Agreement. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to In re Reichhold Holdings US, Inc.,—Gulfport Environmental Response Trust—D.J. Ref. No. 90–11–2–11196. All comments must be submitted so that they are received no later than midnight (Eastern Time) January 29, 2016. Comments may be submitted either by email or by mail: To submit comments: Send them to: By e-mail ...... pubcomment-ees.enrd@ usdoj.gov. Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. By mail ......... Under section 7003(d) of RCRA, a commenter may request an opportunity for a public meeting in the affected area. During the public comment period, the Settlement Agreement may be examined and downloaded at this Justice Department Web site: https:// www.justice.gov/enrd/consent-decrees. We will provide a paper copy of the Settlement Agreement—Gulfport upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. Please enclose a check or money order for $15.00 (25 cents per page reproduction cost) payable to the United States Treasury. Henry Friedman, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 2016–00742 Filed 1–14–16; 8:45 am] BILLING CODE 4410–15–P PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Notice of Filing of Proposed Stipulation and Settlement Agreement Under The Comprehensive Environmental Response, Compensation, and Liability Act On January 12, 2016, a proposed Settlement Agreement between the United States and the Debtors (‘‘Settlement Agreement’’) was filed with the United States Bankruptcy Court for the District of Delaware in the bankruptcy proceeding entitled In re Reichhold Holdings US, Inc., No. 14– 12237–MFW (Bankr. D. Del.). The proposed Settlement Agreement will resolve certain proofs of claim asserted against Debtor Reichhold Inc. under the Comprehensive Environmental Response, Compensation and Liability Act (‘‘CERCLA’’), 42 U.S.C. 9601–9675, for costs incurred and to be incurred by the United States in connection with certain sites, and for natural resource damages and costs of assessment at or in connection with certain sites. Under the proposed Settlement Agreement the United States will have the following allowed general unsecured claims in the above referenced bankruptcy proceeding: 1)With respect to the Peterson/Puritan, Inc. Superfund Site in Rhode Island, the United States on behalf of EPA shall have an Allowed General Unsecured Claim of $205,211; 2) With respect to the Berry’s Creek Study Area operable unit of the Ventron/Velsicol Superfund Site in New Jersey, the United States on behalf of EPA shall have an Allowed General Unsecured Claim of $400,000; 3) With respect to the Lower Passaic River Study Area of the Diamond Alkali Superfund Site in New Jersey, the United States on behalf of EPA shall have an Allowed General Unsecured Claim of $8,000,000; 4) With respect to the Yosemite Slough Superfund Site in California, the United States on behalf of EPA shall have an Allowed General Unsecured Claim of $268,000; 5) With respect to the Lower Duwamish Waterway Superfund Site in Washington: (i) The United States on behalf of EPA shall have an Allowed General Unsecured Claim of $4,300,000; (ii) the United States on behalf of National Oceanic and Atmospheric Administration (‘‘NOAA’’) shall have an Allowed General Unsecured Claim of $5,937; and (iii) the United States on behalf of the Department of Interior (‘‘DOI’’) shall have an Allowed General Unsecured Claim of $558,897.74 (which includes DOI assessment costs of $3,897.74); 6) With respect to the Kin- E:\FR\FM\15JAN1.SGM 15JAN1

Agencies

[Federal Register Volume 81, Number 10 (Friday, January 15, 2016)]
[Notices]
[Pages 2237-2238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00782]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Cambridge 
Isotope Lab

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Cambridge Isotope Lab applied to be registered as a

[[Page 2238]]

manufacturer of a certain basic class of controlled substance. The Drug 
Enforcement Administration (DEA) grants Cambridge Isotope Lab 
registration as a manufacturer of this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated October 2, 2015, and 
published in the Federal Register on October 13, 2015, 80 FR 61470, 
Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810 
applied to be registered as a manufacturer of a certain basic class of 
controlled substance. No comments or objections were submitted for this 
notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Cambridge Isotope Lab to 
manufacture the basic class of controlled substance is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of morphine (9300), a basic class of controlled substance 
listed in schedule II.
    The company plans to utilize small quantities of the listed 
controlled substance in the preparation of analytical standards.

    Dated: January 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-00782 Filed 1-14-16; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.